Apiam Animal Health Management

Management criteria checks 4/4

Apiam Animal Health's CEO is Chris Richards, appointed in Nov 2015, has a tenure of 9.67 years. total yearly compensation is A$595.67K, comprised of 72.5% salary and 27.5% bonuses, including company stock and options. directly owns 22.79% of the company’s shares, worth A$16.43M. The average tenure of the management team and the board of directors is 4 years and 7.6 years respectively.

Key information

Chris Richards

Chief executive officer

AU$595.7k

Total compensation

CEO salary percentage	72.5%
CEO tenure	9yrs
CEO ownership	22.8%
Management average tenure	4yrs
Board average tenure	7.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Chris Richards's remuneration changed compared to Apiam Animal Health's earnings?
Date	Total Compensation	Salary	Company Earnings
Jun 30 2024	n/a	n/a	AU$5m
Mar 31 2024	n/a	n/a	AU$4m
Dec 31 2023	n/a	n/a	AU$3m
Sep 30 2023	n/a	n/a	AU$2m
Jun 30 2023	AU$596k	AU$432k	AU$2m
Mar 31 2023	n/a	n/a	AU$4m
Dec 31 2022	n/a	n/a	AU$6m
Sep 30 2022	n/a	n/a	AU$5m
Jun 30 2022	AU$505k	AU$368k	AU$5m
Mar 31 2022	n/a	n/a	AU$4m
Dec 31 2021	n/a	n/a	AU$4m
Sep 30 2021	n/a	n/a	AU$5m
Jun 30 2021	AU$455k	AU$361k	AU$5m
Mar 31 2021	n/a	n/a	AU$5m
Dec 31 2020	n/a	n/a	AU$5m
Sep 30 2020	n/a	n/a	AU$5m
Jun 30 2020	AU$401k	AU$355k	AU$4m
Mar 31 2020	n/a	n/a	AU$4m
Dec 31 2019	n/a	n/a	AU$3m
Sep 30 2019	n/a	n/a	AU$3m
Jun 30 2019	AU$389k	AU$350k	AU$3m
Mar 31 2019	n/a	n/a	AU$3m
Dec 31 2018	n/a	n/a	AU$3m
Sep 30 2018	n/a	n/a	AU$3m
Jun 30 2018	AU$396k	AU$350k	AU$3m

Compensation vs Market: Chris's total compensation ($USD387.10K) is about average for companies of similar size in the Australian market ($USD297.81K).

Compensation vs Earnings: Chris's compensation has been consistent with company performance over the past year.

CEO

Chris Richards

9yrs

Tenure

AU$595,673

Compensation

Dr. Christopher Irwin Richards, also known as Chris, BSc, BVSc, MAICD, has been Managing Director of Apiam Animal Health Limited since November 1, 2015. Dr. Richards founded Chris Richards & Associates in...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Christopher Richards	MD & Executive Director	9yrs	AU$595.67k	22.79% A$ 16.4m
Matthew White	Chief Financial Officer	no data	AU$347.51k	0.25% A$ 182.4k
Renee Waters	Chief People Officer	no data	AU$258.44k	0.093% A$ 66.7k
Duncan Runciman	Chief Veterinary Officer	less than a year	no data	0.60% A$ 435.0k
Eryl Baron	Company Secretary	4yrs	no data	no data

4.0yrs

Average Tenure

Experienced Management: AHX's management team is considered experienced (4 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Christopher Richards	MD & Executive Director	9.7yrs	AU$595.67k	22.79% A$ 16.4m
Bruce Dixon	Independent Non-Executive Director	less than a year	no data	no data
Andrew Vizard	Independent Non-Executive Chairman	9yrs	AU$140.00k	0.19% A$ 139.6k
Evonne Collier	Independent Non-Executive Director	2.1yrs	AU$52.50k	no data
Richard Dennis	Independent Non-Executive Director	9yrs	AU$80.00k	0.0069% A$ 5.0k
Jan Tennent	Independent Non-Executive Director	6.3yrs	AU$70.00k	0.070% A$ 50.7k

7.6yrs

Average Tenure

Experienced Board: AHX's board of directors are considered experienced (7.6 years average tenure).

Apiam Animal Health Management

Management criteria checks 4/4

Key information

Recent management updates

Apiam Animal Health Limited, Annual General Meeting, Nov 21, 2024

Apiam Animal Health Limited Announces Board Changes

MD & Executive Director recently bought AU$596k worth of stock

Apiam Animal Health Limited, Annual General Meeting, Nov 23, 2023

MD & Executive Director recently bought AU$134k worth of stock

Apiam Animal Health Limited, Annual General Meeting, Nov 24, 2022

Recent updates

Apiam Animal Health Limited, Annual General Meeting, Nov 21, 2024

An undisclosed buyer terminated the acquisition of Apiam Animal Health Limited (ASX:AHX)

Apiam Animal Health Limited Announces Board Changes

Full year 2024 earnings released: EPS: AU$0.028 (vs AU$0.013 in FY 2023)

Apiam Animal Health Limited to Report Fiscal Year 2024 Results on Aug 23, 2024

MD & Executive Director recently bought AU$596k worth of stock

Upcoming dividend of AU$0.01 per share

Apiam Animal Health Limited to Report First Half, 2024 Results on Feb 23, 2024

Apiam Animal Health Limited, Annual General Meeting, Nov 23, 2023

MD & Executive Director recently bought AU$134k worth of stock

New minor risk - Profit margin trend

Full year 2023 earnings released: EPS: AU$0.013 (vs AU$0.034 in FY 2022)

New minor risk - Financial data availability

New minor risk - Share price stability

Apiam Animal Health Limited to Report Fiscal Year 2023 Results on Aug 28, 2023

First half 2023 earnings released: EPS: AU$0.017 (vs AU$0.013 in 1H 2022)

Apiam Animal Health Limited to Report First Half, 2023 Results on Feb 24, 2023

Apiam Animal Health Limited (ASX:AHX) acquired Hunter Equine Centre Pty Ltd for AUD 6.5 million.

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire Harradine and Associates for AUD 2.6 million.

Apiam Animal Health Limited, Annual General Meeting, Nov 24, 2022

MD & Executive Director recently sold AU$354k worth of stock

Full year 2022 earnings released: EPS: AU$0.034 (vs AU$0.042 in FY 2021)

Apiam Animal Health Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2022, Payable on October 21, 2022

Apiam Animal Health Limited to Report Fiscal Year 2022 Results on Aug 29, 2022

Insufficient new directors

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire assets of Victorian Equine Group and Romsey Veterinary Surgery for AUD 13.75 million.

Insufficient new directors

Upcoming dividend of AU$0.012 per share

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Apiam Animal Health Limited Announces Ordinary Fully Franked Dividend for the Period Ended December 31, 2021, Payable on April 20, 2022

Apiam Animal Health Limited to Report First Half, 2022 Results on Feb 25, 2022

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire Fraser Coast Veterinary Services.

MD & Executive Director recently bought AU$96k worth of stock

Apiam Animal Health Limited (ASX:AHX) completed the acquisition of Harbour City Veterinary Surgery.

Insufficient new directors

Full year 2021 earnings released: EPS AU$0.042 (vs AU$0.037 in FY 2020)

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire Harbour City Veterinary Surgery for AUD 2.8 million.

Apiam Animal Health Limited (ASX: AHX) acquired Assets of Golden Plains Animal Hospital.

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire The Scenic Rim for AUD 16 million.

Apiam Animal Health Limited (ASX:AHX) completed the acquisition of Samford Valley Veterinary Hospital.

Apiam Animal Health Limited (ASX:AHX) acquired Clermont Veterinary Surgery.

MD & Executive Director recently bought AU$252k worth of stock

Upcoming Dividend of AU$0.012 Per Share

Apiam Animal Health Limited to Report First Half, 2021 Results on Feb 24, 2021

Apiam Animal Health Limited (ASX:AHX) completed the acquisition of Crosvet Pty Ltd.

Apiam Animal Health Limited Announces Executive Changes, Effective November 30, 2020

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire Crosvet Pty Ltd for AUD 5 million.

New 90-day high: AU$0.66

New 90-day high - AU$0.61

Upcoming Dividend of AU$0.012 Per Share

Full year earnings released - EPS AU$0.037

New 90-day high - AU$0.51

Apiam Animal Health Limited (ASX:AHX) acquired Devoted Vets at Warragul Vic for AUD 0.5 million.

Apiam Animal Health Limited to Report Fiscal Year 2020 Results on Aug 24, 2020

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Board Members

Average Tenure